 |
| Source: Temple University |
The line between physical examinations and imaging may be blurring thanks to a tactile imaging sensor prototype which emulates human sensation from a hands-on exam, but also uses LED lights and a camera to quantify the data. Developed by a team of researchers led by Chang-Hee Won, PhD, of Temple University in Philadelphia, the device could help doctors who feel a breast lump during a physical exam, and determine the probability of the lesion being malignant or benign.
More than half the women aged 40 to 49 diagnosed with breast cancer on screening mammography reported no family history of the disease, supporting the benefit of yearly screening mammography for women in their 40s, according to a study presented May 3 at the annual meeting of the American Roentgen Ray Society in Vancouver.
Otis W. Brawley, MD, chief medical and scientific officer of the American Cancer Society, weighed the pros and cons of risk-based mammography screening in an editorial published May 1 in the
Annals of Internal Medicine. The editorial coincided with the publication of two studies examining risk-based screening for women ages 40 to 49.
Women between the ages of 40 and 49 years who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors than symptomatic women requiring diagnostic workup, according to a study published in the May issue of
American Journal of Roentgenology.
The most common treatment for ductal carcinoma in situ (DCIS) is breast-conserving surgery (BCS) and while the procedure has been shown to be effective at reducing cancer mortality, women undergoing BCS should be prepared for the possibility of future diagnostic mammograms and invasive breast procedures for as long as 10 years after surgery, according to research published online April 5 in the Journal of the National Cancer Institute.
The first 20 years of the Dutch population-based mammography breast cancer screening program have contributed to a drop in deaths from the disease while limiting screening harms such as false positives and overdiagnosis, according to study results reported at the Eighth European Breast Cancer Conference (EBCC-8) in Vienna.
After weeks of contentious debate that garnered national attention, last week Virginia Gov. Bob McDonnell signed into law a bill that would make abdominal ultrasounds mandatory for women seeking abortions in the state.
Breast pain is a common complaint among patients and accounts for anywhere from 45 to 70 percent of breast-related complaints in the primary care setting. While imaging may seem to provide reassurance to patients concerned about the possibility of cancer, initial imaging increases the odds of subsequent clinical services utilization that provides no benefit, according to a study published online Jan. 31 in the
Journal of General Internal Medicine.
The FDA has cleared UE LifeSciences NoTouch BreastScan as an adjunctive diagnostic screening tool for the detection of breast cancer.
The Pink Lotus Breast Center, a breast center focused on the prevention, screening, diagnosis and treatment of breast cancer, has unveiled GE Healthcare's SenoBright, contrast-enhanced spectral mammography (CESM) technology at its flagship breast center in Beverly Hills, Calif.
Although most of the European women’s health imaging system market will decline over the next five years, overall revenues will increase slightly as a result of growth in the breast imaging system segment, due to the introduction and adoption of more expensive and innovative systems, according to Millennium Research Group.
The U.S. Preventive Services Task Force’s (USPSTF) 2009 recommendation against routine breast cancer screening for women younger than age 50 continues to make waves. Recent research has shown that fewer women need undergo clinical screening to save a life than estimated by USPSTF’s analysis, according to a study published in the March issue of the
American Journal of Roentgenology.
U-Systems’ somo•v automated breast ultrasound system has been scheduled for review by the Radiological Devices Panel of the FDA on April 11.
Barco has partnered with researchers at the Perelman School of Medicine at the University of Pennsylvania to develop an integrated system to perform virtual clinical trials of breast cancer screening technology.
As the debate continues over the benefit of screening mammography for women aged 40 to 49, research from Swedish Cancer Institute in Seattle has found that breast cancers detected by mammography in this age group have a better prognosis than those detected by other means, according to a study published in the March issue of
Radiology.
Disagreement over management of four high-risk breast lesions—lobular neoplasia, benign papilloma, radial scar and flat epithelial atypia—demonstrate the need for a prospective trial as current recommendations are not well substantiated, according to an article published in the February issue of the
American Journal of Roentgenology.
Among postmenopausal women with hormone receptor-positive breast cancer, increasing age was associated with a higher risk of death from breast cancer regardless of competing mortality and independent of tumor and treatment characteristics, according to a study in the Feb. 8 issue of the
Journal of the American Medical Association.
Approximately 14 percent of high-risk women completed recommended breast MRI screening at Invision Sally Jobe Breast Centers within one year after the clinic implemented risk assessments and informed primary care providers that high-risk women should undergo breast MRI, according to a study published in the January issue of
Academic Radiology.
The American College of Radiology (ACR), AdMeTech Foundation and European Society of Urogenital Radiology (ESUR) have formed a joint effort to expedite development of standards for the Magnetic Resonance Prostate Imaging Reporting and Data System (MR PI-RADS) modeled after a successful effort in breast cancer care.
VeriTeQ has announced plans to market VeriChip, its passive radiofrequency identification (RFID) microchip, for identifying and tracing the whereabouts of breast implants.
